 Acorda Therapeutics, Inc. NASDAQ:ACOR Q3 2022 Results Conference Call November 1, 2022 4:30 PM ET Company Participants Tierney Saccavino - Investor Relations Ron Cohen - President and Chief Executive Officer Michael Gesser - Chief Financial Officer Conference Call Participants Raghuram Selvaraju - H.C. Wainwright Operator Welcome to Acorda Therapeutics Third Quarter 2022 Financial and Business Update. 